Parabilis Medicines Inc (PBLS)

Parabilis Medicines Inc Azioni (PBLS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30
Durata del periodo	3 mesi
Revenues	0.15
	51.03
Research and Development	39.38
Depreciation and Amortization	0.60
Operating Income/Loss	-50.89
Nonoperating Income/Loss	-1.58
	-52.46
Attributable To Parent	-52.46
Available To Common Stockholders, Basic	-66.96
Basic Average Shares	28.91
Diluted Average Shares	28.91
Basic Earnings Per Share	-2.32
Diluted Earnings Per Share	-2.32